Vericel's IPO

Vericel raised a round of funding on February 04, 1997. Investors include Public.

Vericel, formerly Aastrom Biosciences, develops, manufactures, and markets expanded autologous cell therapies for the treatment of patients with serious diseases and conditions. The company markets tw…

Articles about Vericel's IPO: